UCB NORDIC A/S: Financial statements 2019
CVR: 26688949
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
UCB NORDIC A/S (CVR 26688949) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 39,541,000 and a net result of DKK 3,591,000 compared with DKK 3,268,000 the year before. That is an increase of 14.2% compared with the year before. Equity in the 2019 report amounted to DKK 10,573,000. The solvency ratio was 18%. The company had 26 employees in the financial year.
- Gross Profit
- DKK 39,541,000
- Profit/Loss
- DKK 3,591,000
- Equity
- DKK 10,573,000
- Total Assets
- DKK 58,816,000
- Employees
- 26
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 39.5M | 3.6M | 10.6M | 26 |
| 2018 | - | 34.6M | 3.3M | 10.3M | 24 |
| 2017 | - | 34.8M | 3.7M | 10.6M | 23 |
| 2016 | - | -35.5M | 3.7M | 10.4M | 25 |
| 2015 | - | 33.7M | 2.1M | 8.2M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of December 4, 2019, Ilaria Villa has joined the board of directors of UCB NORDIC A/S.
As of December 4, 2019, Willy Constant Cnops has left the board of directors of UCB NORDIC A/S.
UCB NORDIC A/S has published its annual report for 2018. Gross profit came to DKK 34,615,000, and the net result was DKK 3,268,000.
As of May 13, 2019, Afshin Risseh has joined the board of directors of UCB NORDIC A/S.
As of May 13, 2019, Francois Joseph Gérald Vanier has left the board of directors of UCB NORDIC A/S.
About UCB NORDIC A/S
UCB NORDIC A/S is a Danish company of the type Aktieselskab based in København S, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named UCB NORDICS ApS and CELLTECH NORDIC ApS. The management consists of Mari-Ann Retz. The board consists of Laura Ann Byram (chair), Christina Dyreborg Jeppesen and Jaana Mattila. The company is owned by UCB Pharma SA. The company has 48 employees (2026). In 2025, the company reported a gross profit of DKK 88,278,000 and a net result of DKK 6,014,000 compared with DKK 5,226,000 the year before. Equity in the 2025 report amounted to DKK 18,047,000.